(Total Views: 263)
Posted On: 02/27/2024 7:15:12 AM
Post# of 150
HOMOZYGOSITY - A very, very. Big Deal
https://www.kraiglabs.com/kraig-biocraft-labo...ion-trial/
KRAIG BIOCRAFT LABORATORIES ESTABLISHES HOMOZYGOSITY AND CONFIRMS BAM 1 HYBRID READY FOR SPRING PRODUCTION TRIAL
ANN ARBOR, Mich., – February 27, 2024 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Kraig Labs” or “the Company”), announces that it has achieved homozygosity for the spider silk gene in both of the parental strains for its new production hybrid. Establishing homozygosity for the targeted gene in both parental strains means that the Company’s new BAM 1 hybrid production system is optimized for recombinant spider silk production.
The BAM 1 hybrid represents the Company’s latest innovation in the commercialization of recombinant spider silk technology. Achieving homozygosity for both BAM 1 parental strains is another significant milestone in the commercialization of recombinant spider silk. The reason homozygosity is important is because it results in higher levels of spider silk protein expression.
“Our team set an aggressive deadline for achieving homozygosity in the BAM 1 hybrid ahead of our spring production trials,” said CEO and Founder, Kim Thompson. “Today, I am pleased to report they met that goal and that BAM 1 hybrids, which will be our primary production strain for the upcoming production season, is now optimized for recombinant spider silk expression. Our team continues to hit its marks, and I am looking forward to a very exciting year for Kraig Labs and the commercial launch of our revolutionary spider silk technology.”
——————————————————————————————
Long time investors know exactly what this means. Today the share price will have a very significant rise on this news. This is HUGE .
Hope for the best, Prepare for the worst. Adapt - Improvise - Overcome
"Sic parvis magma" - Greatness from small beginnings
All the best, WBeacham
https://www.kraiglabs.com/kraig-biocraft-labo...ion-trial/
KRAIG BIOCRAFT LABORATORIES ESTABLISHES HOMOZYGOSITY AND CONFIRMS BAM 1 HYBRID READY FOR SPRING PRODUCTION TRIAL
ANN ARBOR, Mich., – February 27, 2024 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Kraig Labs” or “the Company”), announces that it has achieved homozygosity for the spider silk gene in both of the parental strains for its new production hybrid. Establishing homozygosity for the targeted gene in both parental strains means that the Company’s new BAM 1 hybrid production system is optimized for recombinant spider silk production.
The BAM 1 hybrid represents the Company’s latest innovation in the commercialization of recombinant spider silk technology. Achieving homozygosity for both BAM 1 parental strains is another significant milestone in the commercialization of recombinant spider silk. The reason homozygosity is important is because it results in higher levels of spider silk protein expression.
“Our team set an aggressive deadline for achieving homozygosity in the BAM 1 hybrid ahead of our spring production trials,” said CEO and Founder, Kim Thompson. “Today, I am pleased to report they met that goal and that BAM 1 hybrids, which will be our primary production strain for the upcoming production season, is now optimized for recombinant spider silk expression. Our team continues to hit its marks, and I am looking forward to a very exciting year for Kraig Labs and the commercial launch of our revolutionary spider silk technology.”
——————————————————————————————
Long time investors know exactly what this means. Today the share price will have a very significant rise on this news. This is HUGE .
Quote:
THESE are the times that try men’s souls. The summer soldier and the sunshine patriot will, in this crisis, shrink from the service of their country; but he that stands it now, deserves the love and thanks of man and woman.
Hope for the best, Prepare for the worst. Adapt - Improvise - Overcome
"Sic parvis magma" - Greatness from small beginnings
All the best, WBeacham
(0)
(0)
